Role of obesity on the efficacy of exemestane plus ovarian suppression in hormone receptor-positive premenopausal breast cancer

Future Oncol. 2015;11(6):905-7. doi: 10.2217/fon.15.6.
No abstract available

Keywords: aromatase inhibitors; exemestane; ovarian suppression; premenopausal breast cancer; tamoxifen.

Publication types

  • Letter

MeSH terms

  • Androstadienes / pharmacology
  • Androstadienes / therapeutic use*
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Aromatase Inhibitors / pharmacology
  • Aromatase Inhibitors / therapeutic use*
  • Breast Neoplasms / complications*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / mortality
  • Female
  • Humans
  • Obesity / complications*
  • Ovary / drug effects
  • Ovary / metabolism
  • Receptors, Estrogen / metabolism
  • Treatment Outcome

Substances

  • Androstadienes
  • Antineoplastic Agents
  • Aromatase Inhibitors
  • Receptors, Estrogen
  • exemestane